X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1068) 1068
Publication (91) 91
Book Review (30) 30
Book Chapter (19) 19
Reference (2) 2
Book / eBook (1) 1
Conference Proceeding (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
antibiotic-associated diarrhea (713) 713
humans (658) 658
clostridium difficile (413) 413
index medicus (386) 386
diarrhea (325) 325
probiotics (279) 279
pseudomembranous colitis (268) 268
antibiotic-associated colitis (239) 239
microbiology (224) 224
infectious diseases (192) 192
gastroenterology & hepatology (189) 189
male (189) 189
double-blind (186) 186
saccharomyces-boulardii (183) 183
female (178) 178
colitis (173) 173
disease (167) 167
antibiotics (166) 166
placebo-controlled trial (162) 162
probiotics - therapeutic use (162) 162
prevention (152) 152
clostridium difficile - isolation & purification (149) 149
infection (149) 149
risk factors (148) 148
anti-bacterial agents - adverse effects (147) 147
animals (146) 146
adult (141) 141
aged (134) 134
anti-bacterial agents - therapeutic use (134) 134
epidemiology (134) 134
diarrhea - microbiology (132) 132
middle aged (127) 127
pharmacology & pharmacy (126) 126
enterocolitis, pseudomembranous - microbiology (123) 123
risk-factors (123) 123
health aspects (121) 121
toxin-a (117) 117
vancomycin (113) 113
metronidazole (106) 106
irritable-bowel-syndrome (101) 101
microbiota (98) 98
enterocolitis, pseudomembranous - drug therapy (96) 96
feces - microbiology (89) 89
medicine, general & internal (88) 88
enterocolitis, pseudomembranous - epidemiology (87) 87
immunology (87) 87
enterocolitis, pseudomembranous - diagnosis (85) 85
infections (85) 85
child (80) 80
inflammatory bowel disease (80) 80
clostridium difficile - pathogenicity (78) 78
recurrence (76) 76
bacteria (75) 75
diarrhea - chemically induced (75) 75
hospitalized-patients (74) 74
diarrhea - prevention & control (73) 73
diagnosis (72) 72
ulcerative-colitis (68) 68
clostridium difficile - drug effects (67) 67
clostridium infections - microbiology (67) 67
children (66) 66
nutrition & dietetics (66) 66
clostridium-difficile (65) 65
lactobacillus (65) 65
care and treatment (63) 63
diarrhea - drug therapy (63) 63
treatment outcome (63) 63
clostridium infections - epidemiology (62) 62
toxin (62) 62
randomized controlled-trial (60) 60
aged, 80 and over (59) 59
mortality (59) 59
inflammatory-bowel-disease (58) 58
diarrhea - etiology (57) 57
metronidazole - therapeutic use (57) 57
cross infection - microbiology (56) 56
escherichia-coli (56) 56
adolescent (55) 55
enterocolitis, pseudomembranous - therapy (55) 55
incidence (55) 55
lactic-acid bacteria (55) 55
clostridium-difficile colitis (54) 54
diarrhea - epidemiology (54) 54
review (52) 52
vancomycin - therapeutic use (52) 52
analysis (51) 51
antibiotic-associated diarrhoea (51) 51
clostridium infections - drug therapy (51) 51
enterocolitis, pseudomembranous - prevention & control (51) 51
therapy (51) 51
diarrhea - therapy (50) 50
metaanalysis (50) 50
cross infection - epidemiology (49) 49
cross infection - prevention & control (49) 49
infant (49) 49
research (49) 49
child, preschool (48) 48
clostridium infections - diagnosis (48) 48
fecal microbiota transplantation (48) 48
gastrointestinal diseases (47) 47
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (986) 986
French (27) 27
German (27) 27
Spanish (15) 15
Russian (13) 13
Japanese (6) 6
Korean (3) 3
Polish (3) 3
Hungarian (2) 2
Turkish (2) 2
Italian (1) 1
Persian (1) 1
Portuguese (1) 1
Slovenian (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Advances in Experimental Medicine and Biology, ISSN 0065-2598, 2019, Volume 1125, pp. 139 - 146
Journal Article
Inflammatory Bowel Diseases, ISSN 1078-0998, 10/2008, Volume 14, Issue 10, pp. 1432 - 1442
Clostridium difficile colitis has doubled in North America over the past 5 years and recent reports have demonstrated an increase in incidence and severity of... 
infliximab | Clostridium difficile | enteritis | nitazoxanide | pseudomembranous colitis | azathioprine | methotrexate | Crohn's disease | rifaximin | inflammatory bowel disease | 6‐mercaptopurine | fulminant colitis | colectomy | vancomycin | ulcerative colitis | metronidazole | Fulminant colitis | Inflimab | Colectomy | Methotrexoate | Inflammatory bowel disease | 6-mercaptopurine | Nitazoxanide | Vanocomycin | Enteritis | Rifaximin | Metronidazole | Pseudomembranous colitis | Azathioprine | Ulcerative colitis | TOXIN-A | DIARRHEA | ORAL VANCOMYCIN | RANDOMIZED CONTROLLED-TRIAL | INTRAVENOUS IMMUNOGLOBULIN | ANTIBIOTIC-ASSOCIATED COLITIS | CLINDAMYCIN-ASSOCIATED COLITIS | FUSIDIC ACID | GASTROENTEROLOGY & HEPATOLOGY | Crohn Disease - epidemiology | Severity of Illness Index | Prognosis | Risk Assessment | Comorbidity | Humans | Crohn Disease - mortality | Colitis, Ulcerative - pathology | Clostridium Infections - epidemiology | Colitis, Ulcerative - epidemiology | Clostridium difficile - pathogenicity | Inflammatory Bowel Diseases - epidemiology | Colitis, Ulcerative - microbiology | Crohn Disease - pathology | Inflammatory Bowel Diseases - pathology | Colitis, Ulcerative - mortality | Crohn Disease - microbiology | Inflammatory Bowel Diseases - microbiology | Inflammatory Bowel Diseases - mortality | Odds Ratio | Corticoids | Inflammatory bowel diseases | Mortality | Vancomycin | Morbidity | Risk factors | Infection | Algorithms | Databases | Reviews | Antibiotics | Intestine
Journal Article
Inflammatory Bowel Diseases, ISSN 1078-0998, 11/2011, Volume 17, Issue 11, pp. 2235 - 2250
Background: Probiotics have been clinically administered to improve intestinal damage in some intestinal inflammations. However, probiotic treatments are not... 
IL‐1β | IL‐12 | proinflammatory cytokines | Lactobacillus brevis | TNF‐α | heat shock protein | barrier function | p38MAPK | TNF-α | IL-1β | IL-12 | ORAL BACTERIOTHERAPY | SACCHAROMYCES-BOULARDII | PROBIOTIC BACTERIA | TNF-alpha | ESCHERICHIA-COLI | ULCERATIVE-COLITIS | IL-1 beta | ANTIBIOTIC-ASSOCIATED DIARRHEA | TOLL-LIKE RECEPTORS | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | GASTROENTEROLOGY & HEPATOLOGY | PREVENT NECROTIZING ENTEROCOLITIS | Intestinal Diseases - prevention & control | Tumor Necrosis Factor-alpha - metabolism | Humans | Tumor Necrosis Factor-alpha - genetics | Male | Interleukin-1beta - genetics | Lactobacillus brevis - metabolism | Colitis - mortality | Interleukin-1beta - metabolism | Colitis - chemically induced | Real-Time Polymerase Chain Reaction | Mice, Inbred C57BL | RNA, Messenger - genetics | Cells, Cultured | Survival Rate | Interleukin-12 - metabolism | Hot Temperature | Blotting, Western | Dextran Sulfate - toxicity | Animals | Colitis - microbiology | Intestinal Diseases - microbiology | Mitogen-Activated Protein Kinases - genetics | Probiotics - therapeutic use | Mice | Intestinal Diseases - pathology | Mitogen-Activated Protein Kinases - metabolism | Animal models | Inflammatory bowel diseases | Phosphorylation | Cytokines | Heat shock proteins | Homeostasis | Interleukin 12 | MAP kinase | Small intestine | Survival | Stress | Western blotting | Dextran | Oxidants | Intestine | Models | Colitis | sodium sulfate | Colonization | Injuries | Tumor necrosis factor- alpha | probiotics
Journal Article
Journal Article